| 1 |
Investigating Commercial Incentives for Innovation: An Application in Traditional Medicine |
|
| | Debdatta Saha, T. M. Vasuprada | | | Studies in Microeconomics. 2021; 9(1): 66 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Pitfalls and promises of raw drug identification techniques in the ayurvedic industry: an overview |
|
| | Remya Unnikrishnan, Suma Arun Dev, R. Jayaraj | | | 3 Biotech. 2020; 10(11) | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Dipeptidyl peptidase 8 and 9 - Guilty by association? |
|
| | Pitman, M.R., Sulda, M.L., Kuss, B., Abbott, C.A. | | | Frontiers in Bioscience. 2009; 14(10): 3619-3633 | | | [Pubmed] [Google Scholar] | | | 4 |
Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of type 2 diabetes |
|
| | Gupta, R., Walunj, S.S., Tokala, R.K., Parsa, K.V.L., Singh, S.K., Pal, M. | | | Current Drug Targets. 2009; 10(1): 71-87 | | | [Pubmed] [Google Scholar] | |
|
